Evaluation unit for inhalers

Cavatorta , et al. February 15, 2

Patent Grant D943733

U.S. patent number D943,733 [Application Number D/737,702] was granted by the patent office on 2022-02-15 for evaluation unit for inhalers. This patent grant is currently assigned to APTAR RADOLFZELL GMBH. The grantee listed for this patent is Aptar Radolfzell GmbH. Invention is credited to Matthieu Cavatorta, Line Huchet, Matthieu Walter.


United States Patent D943,733
Cavatorta ,   et al. February 15, 2022

Evaluation unit for inhalers

Claims

CLAIM The ornamental design for an evaluation unit for inhalers, as shown and described.
Inventors: Cavatorta; Matthieu (Autouillet, FR), Huchet; Line (Saint-Germain en Laye, FR), Walter; Matthieu (Villepreux, FR)
Applicant:
Name City State Country Type

Aptar Radolfzell GmbH

Radolfzell

N/A

DE
Assignee: APTAR RADOLFZELL GMBH (Radolfzell, DE)
Appl. No.: D/737,702
Filed: June 11, 2020

Foreign Application Priority Data

Apr 30, 2020 [EM] 007849666
Current U.S. Class: D24/110; D24/110.5
Current International Class: 2402
Field of Search: ;D24/107,108,110,110.1-110.5,127,164,190,113 ;D9/448 ;D28/7

References Cited [Referenced By]

U.S. Patent Documents
D358880 May 1995 Mulhauser
D541654 May 2007 Pietrowski
D561890 February 2008 Lithgow
D577998 October 2008 Decottignies
D583463 December 2008 Wood
D625186 October 2010 Rossignol
D659819 May 2012 Edwards
D666909 September 2012 Bloc
D678503 March 2013 Schmidt
D683445 May 2013 Inoue
D702401 April 2014 Phillips
D733287 June 2015 Bilgic
D740948 October 2015 Hamilton
D751182 March 2016 Huang
D765831 September 2016 Li
10239085 March 2019 Paunescu
D888931 June 2020 Li
D888932 June 2020 Jung
10835694 November 2020 Lastow
D909670 February 2021 Li
10953164 March 2021 McGuckin
D930473 September 2021 Righi
2015/0014434 January 2015 Fedorov
Foreign Patent Documents
007849666-0001 Apr 2020 EM
9007849666-0001 Apr 2020 GB

Other References

Orbital.RTM. Dry Powder Inhaler, pharmaxis/ Aptar Radolfzell GmbH, [Postdate unknown], [Site seen Nov. 23, 2021], Seen at URL: https://www.pharmaxis.com.au/product-pipeline/other-pipeline-assets/orbit- al-dry-powder-inhaler/ (Year: 2021). cited by examiner .
U.S. Appl. No. 29/734,519, filed May 13, 2020. cited by applicant.

Primary Examiner: Vujcic; Natasha
Assistant Examiner: Ford; Gilbert B
Attorney, Agent or Firm: Flynn Thiel, P.C.

Description



FIG. 1 is a perspective view of an evaluation unit for inhalers showing our new design;

FIG. 2 is a front view thereof;

FIG. 3 is a right side view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a top view thereof; and,

FIG. 7 is a bottom view thereof.

The broken lines in the drawings illustrate portions of the evaluation unit for inhalers and form no part of the claimed design.

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed